New impacts of cutaneous lupus erythematosus for global standard concepts

Autoimmunity Reviews

Volumn 8, Issue 6, 2009, Pages 439-440

  Furukawa, Fukumi ^a   Matsuura, Eiji ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; DERMATOMYOSITIS; EDITORIAL; SJOEGREN SYNDROME; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; VASCULITIS;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; DERMATOMYOSITIS; HUMANS; JAPAN; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MODELS, IMMUNOLOGICAL; SJOGREN'S SYNDROME;

EID: 65549144914     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.12.009     Document Type: Editorial

References (20)

1. Kuhn A., Rondinone R., Doria A., and Shoenfeld Y. 1st International Conference on Cutaneous Lupus Erythematosus Düsseldorf, Germany, September 1-5, 2004. Autoimmun Rev 4 (2005) 66-78
2. Furukawa F., and Yoshimasu T. Animal models of spontaneous and drug-induced cutaneous lupus erythematosus. Autoimmun Rev 4 (2005) 345-350
3. Lee L.A. Transient autoimmunity related to maternal autoantibodies: neonatal lupus. Autoimmun Rev 4 (2005) 207-213
4. Sontheimer R.D. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 4 (2005) 253-263
5. Furukawa F, Kuhn A, Lehmann P, Mimori T, Ruzicka T, Sontheimer RD, et al. 2nd International Conference onCutaneous Lupus Erythematosus (ICCLE), Arch Dermatol Res 2009;301:33-55.
6. Bashir MM, Sharma MR, Werth VP. TNF-α production in the skin, Arch Dermatol Res 2009;301:87-91.
7. Sontheimer RD, Clifford L, Henderson CL, Grau RH. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res 2009;301:65-70.
8. Furukawa F, Muto M. Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus, Arch Dermatol Res 2009;301:111-115.
9. Sardy M, Ruzicka T, Kuhn A. Topical calcineurin inhibitors in cutaneous lupus erythematosus, Arch Dermatol Res 2009;301:93-98.
10. Nancy AL, Shoenfeld Y. Prediction and prevention of autoimmune skin disorders, Arch Dermatol Res 2009;301:57-64.
11. Kuhn A, Bein D, Bonsmann G. The 100th Anniversary of Lupus Erythematosus Tumidus, Autoimmun Rev 2009-this issue.
12. Arai S, Katsuoka K. Clinical entity of lupus erythematosus panniculitis/lupus erythematosus profundus, Autoimmun Rev 2009-this issue.
13. Tsuchida T. Classification of lupus erythematosus based upon Japanese patients, Autoimmun Rev 2009-this issue.
14. Lehmann P, Homey B. Clinic and pathophysiology of photosensitivity in lupus erythematosus, Autoimmun Rev 2009-this issue.
15. Kobayashi R, Mii S, Nakano T, Harada H, Eto H. Neonatal lupus erythematosus in Japan: a review of the literature, Autoimmun Rev 2009-this issue.
16. Baltaci M, Fritsch P. Histologic features of cutaneous lupus erythematosus, Autoimmun Rev 2009-this issue.
17. Al-Refu K, Goodfield M. Hair follicle stem cells in the pathogenesis of the scarring process in cutaneous lupus erythematosus, Autoimmun Rev 2009-this issue.
18. Harries MJ, Meyer K, Paus R. Hair loss as a result of cutaneous autoimmunity: frontiers in the immunopathogenesis of primary cicatricial alopecia, Autoimmun Rev 2009-this issue.
19. Ghoreishi M, Dutz JP. Murine models of cutaneous involvement in lupus erythematosus, Autoimmun Rev 2009-this issue.
20. Aota N, Shiohara T. Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes, Autoimmun Rev 2009-this issue.